Search Results - "Fomina, D S"
-
1
Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study
Published in BMC infectious diseases (22-12-2021)“…Several anti-cytokine therapies were tested in the randomized trials in hospitalized patients with severe acute respiratory syndrome coronavirus 2 infection…”
Get full text
Journal Article -
2
Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma
Published in Terapevtic̆eskii arhiv (15-12-2020)“…During last few years, the approaches to the management of patients with severe asthma have been revised. Monoclonal antibodies (MABs), inhibitors of…”
Get full text
Journal Article -
3
Development of Instruments for Audit Quality Assessment and Control
Published in Učët. Analiz. Audit (Online) (27-10-2019)“…The role of audit firms as independent institutions certifying the reliability of reporting information disclosed by businesses to the wide range of interested…”
Get full text
Journal Article -
4
Significance of individual management plan for the patients with hereditary lymphangioedema during pregnancy and lactation, and in newborns
Published in Medit͡s︡inskai͡a︡ immunologii͡a (21-05-2020)“…Hereditary angioedema (HAE) is a genetically caused orphan disease with a high risk of developing life-threatening attacks, thus requiring availability for…”
Get full text
Journal Article -
5
Baricitinib in the Treatment of Patients with COVID-19: A Review of International Data and Analysis of Clinical Results in the Russian Population
Published in Антибиотики и Химиотерапия (06-05-2021)“…The effects of baricitinib, a selective reversible inhibitor of Janus kinase 1 and 2, in the treatment of COVID-19 are associated with different aspects of…”
Get full text
Journal Article -
6
Common variable immune deficiency in adults: focus on pulmonary complications
Published in Terapevtic̆eskii arhiv (2017)“…Common variable immune deficiency is the most common form of a group of primary immunodeficiencies in adult patients. Pulmonary complications occupy leading…”
Get full text
Journal Article -
7
Photoplethysmography as a New Tool for Dermographism Quantitive Evaluation
Published in 2024 Wave Electronics and its Application in Information and Telecommunication Systems (WECONF) (03-06-2024)“…Dermographism urticaria, which affects up to 5% of the general population, is defined by intensive reaction to mechanic impact on skin expressed in wheals and…”
Get full text
Conference Proceeding -
8
The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting
Published in Terapevtic̆eskii arhiv (26-12-2022)“…Clinical and laboratory signs of hyperinflammatory response in COVID-19 may serve as prognostic markers of the disease scenario. In real-world practice, there…”
Get full text
Journal Article -
9
To the problem of somatic-hypochondriac paranoia
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)“…To unite within the framework of a single clinical entity (based on the model of hypochondriacal paranoia) phenomena of the somatopsychotic and hypochondriacal…”
Get more information
Journal Article -
10
Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study)
Published in Terapevtic̆eskii arhiv (29-09-2023)“…Dupilumab, a fully human monoclonal antibody directed against the common α-subunit of interleukin (IL)-4 receptors and blocking signaling from both IL-4 and…”
Get full text
Journal Article -
11
The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic
Published in Terapevtic̆eskii arhiv (11-10-2023)“…On July 3, 2023, an interdisciplinary Council of Experts "The burden of COVID-19 in a heterogeneous population of immunocompromised patients - post-pandemic…”
Get full text
Journal Article -
12
Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study
Published in Terapevtic̆eskii arhiv (17-08-2023)“…To evaluate the efficacy and safety of a combination of virus-neutralizing monoclonal antibodies - MAB (casirivimab and imdevimab) in patients with mild to…”
Get full text
Journal Article -
13
Analysis of predictors of response to anti-IgE therapy in patients with severe atopic bronchial asthma in real clinical practice
Published in Terapevtic̆eskii arhiv (15-03-2022)“…Introduction. Guidelines on Biological Therapy for Bronchial Asthma of the European Academy of Allergy and Clinical Immunology (EAACI) identified a number of…”
Get full text
Journal Article -
14
Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies
Published in Terapevtic̆eskii arhiv (24-02-2023)“…Primary immunodeficiencies (PIDs), now known as inborn errors of immunity, are a group of inherited diseases caused by defects in the genes that control the…”
Get full text
Journal Article -
15
Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit
Published in Terapevtic̆eskii arhiv (17-06-2022)“…Background. The use of virus-neutralizing monoclonal antibodies is an effective method of etiotropic therapy for SARS-CoV-2 in patients of high-risk groups of…”
Get full text
Journal Article -
16
Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19
Published in Terapevtic̆eskii arhiv (15-11-2021)“…Aim. To determine the criteria for the optimal use of IL-6 receptor blockers in patients with COVID-19 community-acquired pneumonia based on predictors of…”
Get full text
Journal Article -
17
Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients’ treatment
Published in Terapevtic̆eskii arhiv (17-06-2022)“…Aim. To study the effect of levilimab or baricitinib in combination with standard therapy (ST) on the incidence of severe viral pneumonia associated with a new…”
Get full text
Journal Article -
18
Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board
Published in Terapevtic̆eskii arhiv (26-05-2022)“…Asthma and chronic obstructive pulmonary disease remain major problems of medicine, and still there is need to improve the level and quality of diagnosis of…”
Get full text
Journal Article -
19
Milk-Specific IgE Reactivity Without Symptoms in Albumin-Sensitized Cat Allergic Patients
Published in Allergy, asthma & immunology research (01-07-2021)“…KCI Citation Count: 0…”
Get full text
Journal Article -
20
Clinical cases: asthma and obesity
Published in Clinical and translational allergy (23-03-2015)Get full text
Journal Article